Literature DB >> 26923578

Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage.

Mo Yunchang1, Dai Qinxue, Ji Binbin, He Xin, Yang Lili, Chen Linbi, Geng Wujun, Zhang Pengbo, Wang Junlu.   

Abstract

OBJECTIVES: Cerebral vasospasm (CVS) and early brain injury are major causes of morbidity and mortality following subarachnoid hemorrhage (SAH). We investigated the efficiency of human tissue kallikrein (HTK) to prevent CVS in a rabbit model of SAH.
METHODS: Forty-eight Japanese white rabbits were randomly divided into four groups (n = 12 each): control (sham-operated), SAH, SAH + phosphate-buffered saline (PBS, vehicle), and SAH + HTK. Basilar artery (BA) diameters were measured by three-dimensional computed tomography angiography at three time points. Endothelin-1 (ET-1) and nitric oxide (NO) levels in the cerebrospinal fluid (CSF) were assayed 24 h before and 5 and 7 days after SAH. After the last measurement, the animals were killed, and endothelial cell apoptosis was assessed. Bax and Bcl-2 levels in the BA were measured by western blotting.
RESULTS: HTK was found to significantly reduce CVS following SAH in rabbits. Inverse changes were observed in ET-1 and NO levels in the CSF collected from the SAH group. HTK increased levels of NO, which has a vasodilatory effect, but did not affect levels of ET-1, which has a vasoconstrictive effect. CTA revealed that HTK treatment significantly increased BA diameter. Moreover, HTK treatment reduced the number of apoptotic cells following SAH, presumably by increasing and decreasing Bcl-2 and Bax expression, respectively.
CONCLUSION: HTK ameliorated CVS and inhibited apoptosis in the BA in a rabbit model of SAH.

Entities:  

Keywords:  Apoptosis; Cerebral vasospasm; Cerebrovascular endothelial cell; Endothelin-1; Human tissue kallikrein; Nitric oxide; Subarachnoid hemorrhage

Mesh:

Substances:

Year:  2015        PMID: 26923578     DOI: 10.1080/01616412.2015.1110305

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

Review 1.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

2.  Ethyl pyruvate attenuates delayed experimental cerebral vasospasm following subarachnoid haemorrhage in rats: possible role of JNK pathway.

Authors:  Ke Jin; Hui Wu; Tao Lv; Jiong Dai; Xiaohua Zhang; Yichao Jin
Journal:  RSC Adv       Date:  2018-02-16       Impact factor: 4.036

3.  An experimental rabbit model of symptomatic cerebral vasospasm with in vivo neuroimaging assessment and ex vivo histological validation.

Authors:  Yunchang Mo; Luping Huang; Linbi Chen; Michael Veronesi; Yiyi Shi; Sijia Chen; Linli Peng; Leping Zhou; Yonglin Pu; Junlu Wang
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

4.  Expression of caspase-3, Bax and Bcl-2 in hippocampus of rats with diabetes and subarachnoid hemorrhage.

Authors:  Xin He; Jiankui Sun; Xiaoyu Huang
Journal:  Exp Ther Med       Date:  2017-11-03       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.